Louvain-La-Neuve, Belgium, and BELOIT, Wisconsin, USA September 20, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and NorthStar Medical ...
Louvain-La-Neuve, Belgium, and BELOIT, Wis., USA November 18, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and NorthStar Medical ...
BELOIT—NorthStar Medical Radioisotopes, LLC will be purchasing a third Rhodotron® TT300 HE electron beam accelerator from IBA. The accelerator will be exclusively used for the production of no-carrier ...
− NorthStar positioned for continued strong growth and setting leadership standards for domestic, environmentally sustainable radioisotope production across its portfolio to meet needs of health ...
TerraPower Isotopes and Belgian joint venture PanTera have announced a collaboration to increase the global availability of actinium-225, while Arizona-based Serva Energy has developed a new research ...
BELOIT, Wis. & LOUVAIN-LA-NEUVE, Belgium--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and commercialization of ...
Louvain-La-Neuve, Belgium, and BELOIT, Wis., USA November 18, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and NorthStar Medical ...
- NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA's environmentally preferable Rhodotron accelerator technology - NorthStar Medical ...
NorthStar Medical Radioisotopes, LLC ('NorthStar'), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback